MetaCap

Trevi Therapeutics Statistics

NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.35-0.37 (-2.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Trevi Therapeutics by the numbers

Trevi Therapeutics has a market capitalization of $1.90 billion based on 142.56M shares outstanding. With trailing EPS of $-0.40, Trevi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.8% below its 50-day average and 8.5% below its 200-day average.

Average daily trading volume is 2.00M shares, or about $26.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TRVI valuation vs. peer median

TRVI compared with the median of 8 peer companies
MetricTRVIPeer medianDifference
Market cap$1.90B$1.85B+3%
Avg. volume2.00M1.23M+63%

Peer median across 8 companies: HRMY, BHVN, IMNM, VERA, AUPH, SEPN, MRVI, ZYME.

Valuation

Price and trading

Previous close
13.72
Open
13.58
Day range
13.23 – 13.90
52-week range
9.82 – 20.22
52-week change
+21.47%
Beta
—
Volume
2.09M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.90B
Forward Pe
-21.99
Eps
-0.40
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
20.22
Week52 Low
9.82
Avg Volume
2.00M
Shares Outstanding
142.56M
Ma50
13.73
Ma200
14.58
Earnings Date
Nov 9, 2026
Pct From52w High
-33.98%
Pct From52w Low
35.95%

Related